ASP International GmbH, a division of Fortive, announced that its ULTRA GI™ Cycle for the STERRAD™ 100NX Sterilizer—developed in partnership with FUJIFILM Healthcare Europe GmbH—has received CE mark approval. The cycle, designed specifically for duodenoscope reprocessing, leverages ALLClear™ Technology to improve microbial reduction by an estimated 4-log reduction over current high‐level disinfection standards. This regulatory milestone clears the way for launch across 27 European markets, positioning FUJIY to capture a share of the €200 million endoscope reprocessing segment. Investors should note that debut installations are planned in five major teaching hospitals in Germany and France by Q3, with roll-out agreements in place covering more than 150 additional sites through 2026.

FUJIFILM North America’s Imaging Division unveiled the instax mini Link+™ smartphone printer, the latest addition to its instant-print portfolio. The mini Link+ delivers credit-card-sized prints in approximately 12 seconds and connects via Bluetooth Low Energy to the free instax mini Link™ app, which now features three new print modes—Party Print, Video Print and Frame Print—designed to drive user engagement and app-based sales of instax film packs. The device, weighing 209 grams with dimensions of 90.3 × 34.6 × 124.4 mm, achieves up to 100 prints per full battery charge. FUJIY anticipates North American roll-out in late Q2, targeting the youth and social-media markets, with initial production volumes scaled to 200,000 units in fiscal 2026. This launch reinforces Fujifilm’s strategy to offset declining analog film revenues and capitalise on the growing instant-photo segment, valued at an estimated $1.1 billion globally.